Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
PLX

Protalix BioTherapeutics (PLX) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $2.78 +3.0% on the day +8.6% over 12 months 52-week range $1.67 – $3.15

Share price and insider trades

PLX closeInsider buyInsider sale
1.502.002.503.003.50NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $314 on 2025-11-18 · Amos Bar-shalevBought $101,360 on 2025-12-19 · Dror Bashan
Bought, 12 months$101K
Sold, 12 months$314
Insiders buying1
Insiders selling1

Protalix BioTherapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $101K and 1 sold $314 of PLX stock on the open market.

PLX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $101K bought (1 trades)$101KQ4 2025: $314 sold (1 trades)Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026—0—0
Q4 2025$101K1$3141

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit+$54KOn all tracked purchases +53.6%

Summary

Over the past 12 months, 1 Protalix BioTherapeutics, Inc. insider reported open-market purchases totaling $101K, while 1 insider reported sales totaling $314. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Dec 23SEC Dror BashanCEO, President Buy 56,000188,516 held (+42%) $1.81 $101K +53.6% —
Nov 19SEC Amos Bar-shalevDirector Sell 168 $1.87 $314 +48.7% —

Insiders at Protalix BioTherapeutics, Inc.

InsiderBoughtSoldLast filingScore
Dror BashanCEO, President $101K — Dec 23, 2025 —
Amos Bar-shalevDirector — $314 Nov 19, 2025 —

PLX stock: common questions

Are Protalix BioTherapeutics, Inc. insiders buying PLX stock?

In the past 12 months, 1 insiders reported open-market purchases of PLX worth $101K. The latest was CEO, President Dror Bashan bought $101K of PLX at $1.81 — first open-market purchase in our records; raises the stake by 42%.

Are Protalix BioTherapeutics, Inc. insiders selling PLX stock?

1 insiders reported sales worth $314 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PLX's 52-week range?

Over the past year PLX has traded between $1.67 and $3.15. It last closed at $2.78 on Oct 9, 2026.